Recent progress in the treatment of acute lymphoblastic leukemia

Author(s)

• Stock, Wendy
• Wetzler, Meir

Bibliographic Information

Recent progress in the treatment of acute lymphoblastic leukemia

guest editors, Wendy Stock, Meir Wetzler

（Hematology/oncology clinics of North America, v. 23, no. 5）

Saunders, c2009

Note

Includes bibliographical references and index

Description and Table of Contents

Description

Acute lymphoblastic leukemia (ALL) is the most common malignancy diagnosed in children, representing nearly one third of all pediatric cancers. The annual incidence of ALL is about 30 cases per million people, with a peak incidence in children aged 2-5 years. Although a few cases are associated with inherited genetic syndromes, the cause of ALL remains largely unknown. This issue presents articles that discuss current thinking on the diagnosis and treatment of the disease. Articles specifically emphasize molecular genetics, allogeneic stem cell transplantation, and treatments including, clofarabine, nelarabine, rituximab, and PegAsp.

by "Nielsen BookData"

Details

• NCID: BB10325884
• ISBN:
  • 9781437712278
• Country Code: us
• Title Language Code: eng
• Text Language Code: eng
• Place of Publication: Philadelphia, Pa.
• Pages/Volumes: xviii, p. [949]-1154
• Size: 24 cm
• Classification:
  • NLM : WH 250
• Subject Headings:
  • MESH : Precursor Cell Lymphoblastic Leukemia-Lymphoma -- therapy
  • LCSH : Lymphoblastic leukemia in children
• Parent Bibliography ID:
  • BA74404928